AI reads brain scans to spot deadly tumors without surgery

NCT ID NCT07673692

First seen Jun 29, 2026 · Last updated Jun 30, 2026 · Updated 1 time

Summary

This study tests whether an artificial intelligence system called GliomaAI-GBM can detect a specific aggressive brain tumor (IDH wildtype glioblastoma) using routine MRI scans. Researchers will analyze previously collected, anonymized MRI data from 1,372 patients across 13 hospitals. The goal is to see how accurately the AI can identify these tumors compared to standard genetic testing after surgery. No new scans or treatments are involved.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
GliomaAI-GBM (artificial intelligence software)
What this could lead to
If successful, this AI could help doctors quickly identify aggressive brain tumors from standard MRI scans, potentially speeding up diagnosis and treatment decisions.
What could go wrong
This is an early-stage study using existing data, not a real-world test. The AI may not perform as well across different hospitals or patient groups, and it is not yet proven to improve patient outcomes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GLIOBLASTOM WHO GRADE 4 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Deep Learning Institute of Radiological Sciences

    Mumbai, India

More trials for these conditions

Other studies related to the condition(s) this trial covers.